The findings showing that older patients with chronic myeloid leukemia (CML) had poor adherence to tyrosine kinase inhibitors (TKIs) was presented last month during the American Society of Hematology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback